Vaccines in pregnancy

The dual benefit for pregnant women and infants

H. Marshall, M. McMillan, R. M. Andrews, K. Macartney, K. Edwards

Research output: Contribution to journalReview articleResearchpeer-review

Abstract

Maternal immunization has the potential to reduce the burden of infectious diseases in the pregnant woman and her infant. Many countries now recommend immunization against influenza at any stage of pregnancy and against pertussis in the third trimester. Despite evidence of the safety and effectiveness of these vaccines when administered during pregnancy, uptake generally remains low for influenza and moderate for pertussis vaccine. Enhancing confidence in both immunization providers and pregnant women by increasing the evidence-base for the safety and effectiveness of vaccines during pregnancy, improving communication and access by incorporating immunization into standard models of antenatal care are likely to improve uptake. Developing a framework for implementation of vaccines for pregnant women which is cognizant of local and national cultural, epidemiological, behavioral and societal factors will enable a smooth transition and high uptake for new vaccines currently in development for pregnant women.

Original languageEnglish
Pages (from-to)848-856
Number of pages9
JournalHuman Vaccines and Immunotherapeutics
Volume12
Issue number4
DOIs
Publication statusPublished - 2 Apr 2016

Fingerprint

Pregnant Women
Immunization
Vaccines
Pregnancy
Human Influenza
Pertussis Vaccine
Safety
Prenatal Care
Whooping Cough
Third Pregnancy Trimester
Communicable Diseases
Communication
Mothers

Cite this

Marshall, H. ; McMillan, M. ; Andrews, R. M. ; Macartney, K. ; Edwards, K. / Vaccines in pregnancy : The dual benefit for pregnant women and infants. In: Human Vaccines and Immunotherapeutics. 2016 ; Vol. 12, No. 4. pp. 848-856.
@article{67634bef21a4445daafd711a41f5362b,
title = "Vaccines in pregnancy: The dual benefit for pregnant women and infants",
abstract = "Maternal immunization has the potential to reduce the burden of infectious diseases in the pregnant woman and her infant. Many countries now recommend immunization against influenza at any stage of pregnancy and against pertussis in the third trimester. Despite evidence of the safety and effectiveness of these vaccines when administered during pregnancy, uptake generally remains low for influenza and moderate for pertussis vaccine. Enhancing confidence in both immunization providers and pregnant women by increasing the evidence-base for the safety and effectiveness of vaccines during pregnancy, improving communication and access by incorporating immunization into standard models of antenatal care are likely to improve uptake. Developing a framework for implementation of vaccines for pregnant women which is cognizant of local and national cultural, epidemiological, behavioral and societal factors will enable a smooth transition and high uptake for new vaccines currently in development for pregnant women.",
keywords = "immunization, influenza, maternal immunization, pertussis, pregnant women, vaccines",
author = "H. Marshall and M. McMillan and Andrews, {R. M.} and K. Macartney and K. Edwards",
year = "2016",
month = "4",
day = "2",
doi = "10.1080/21645515.2015.1127485",
language = "English",
volume = "12",
pages = "848--856",
journal = "Human Vaccines",
issn = "1554-8600",
publisher = "Taylor & Francis",
number = "4",

}

Vaccines in pregnancy : The dual benefit for pregnant women and infants. / Marshall, H.; McMillan, M.; Andrews, R. M.; Macartney, K.; Edwards, K.

In: Human Vaccines and Immunotherapeutics, Vol. 12, No. 4, 02.04.2016, p. 848-856.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Vaccines in pregnancy

T2 - The dual benefit for pregnant women and infants

AU - Marshall, H.

AU - McMillan, M.

AU - Andrews, R. M.

AU - Macartney, K.

AU - Edwards, K.

PY - 2016/4/2

Y1 - 2016/4/2

N2 - Maternal immunization has the potential to reduce the burden of infectious diseases in the pregnant woman and her infant. Many countries now recommend immunization against influenza at any stage of pregnancy and against pertussis in the third trimester. Despite evidence of the safety and effectiveness of these vaccines when administered during pregnancy, uptake generally remains low for influenza and moderate for pertussis vaccine. Enhancing confidence in both immunization providers and pregnant women by increasing the evidence-base for the safety and effectiveness of vaccines during pregnancy, improving communication and access by incorporating immunization into standard models of antenatal care are likely to improve uptake. Developing a framework for implementation of vaccines for pregnant women which is cognizant of local and national cultural, epidemiological, behavioral and societal factors will enable a smooth transition and high uptake for new vaccines currently in development for pregnant women.

AB - Maternal immunization has the potential to reduce the burden of infectious diseases in the pregnant woman and her infant. Many countries now recommend immunization against influenza at any stage of pregnancy and against pertussis in the third trimester. Despite evidence of the safety and effectiveness of these vaccines when administered during pregnancy, uptake generally remains low for influenza and moderate for pertussis vaccine. Enhancing confidence in both immunization providers and pregnant women by increasing the evidence-base for the safety and effectiveness of vaccines during pregnancy, improving communication and access by incorporating immunization into standard models of antenatal care are likely to improve uptake. Developing a framework for implementation of vaccines for pregnant women which is cognizant of local and national cultural, epidemiological, behavioral and societal factors will enable a smooth transition and high uptake for new vaccines currently in development for pregnant women.

KW - immunization

KW - influenza

KW - maternal immunization

KW - pertussis

KW - pregnant women

KW - vaccines

UR - http://www.scopus.com/inward/record.url?scp=84969551384&partnerID=8YFLogxK

U2 - 10.1080/21645515.2015.1127485

DO - 10.1080/21645515.2015.1127485

M3 - Review article

VL - 12

SP - 848

EP - 856

JO - Human Vaccines

JF - Human Vaccines

SN - 1554-8600

IS - 4

ER -